High-throughput sequencing of chemosensitive small cell lung cancer cell lines H82 and DMS114, and their corresponding chemoresistant counterparts
RNA-seq (gene expression) · human · 12 samples
- What it is
- RNA-seq (gene expression)Gene activity measured by sequencing. The summary does not mention single-cell work, so this is most likely bulk: one average per sample, the usual starting point for comparing groups.
- Organism
- Homo sapiens (human)
- Topic
- Small cell lung cancerThis series is part of our curated briefing on it.
- Samples
- 12 samples: 3 × H82, parental, vs 3 × H82DDP, cisplatin-induced, vs 3 × DMS114, parental, vs 3 × DMS114DDP, cisplatin-induced,Groups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
- Paper
- KDM4B/DHX9 promotes chemoresistance in small-cell lung cancer through the MYCN-driven signaling pathwayOncogene · 2026
Read the full summary ↓
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE313099_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: For RNA-seq the counts are usually a table among the supplementary files (look for 'counts', 'expression', 'FPKM' or 'TPM' in the file name). The series matrix of a sequencing study is sometimes nearly empty.
Also filed as BioProject PRJNA1378256 and SRA study SRP653847. Searching any of these in the dataset finder brings you back here.
Supports a case/control comparison: 6 samples read as cases, 6 as controls.
How we read this: 4 replicated groups read from 12 sample titles; they account for 12 of them. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM9360902 H82, parental, rep1 H82, parental,
- GSM9360903 H82, parental, rep2 H82, parental,
- GSM9360904 H82, parental, rep3 H82, parental,
- GSM9360905 H82DDP, cisplatin-induced, rep1 H82DDP, cisplatin-induc…
- GSM9360906 H82DDP, cisplatin-induced, rep2 H82DDP, cisplatin-induc…
- GSM9360907 H82DDP, cisplatin-induced, rep3 H82DDP, cisplatin-induc…
- GSM9360908 DMS114, parental, rep1 DMS114, parental,
- GSM9360909 DMS114, parental, rep2 DMS114, parental,
- GSM9360910 DMS114, parental, rep3 DMS114, parental,
- GSM9360911 DMS114DDP, cisplatin-induced, rep1 DMS114DDP, cisplatin-in…
- GSM9360912 DMS114DDP, cisplatin-induced, rep2 DMS114DDP, cisplatin-in…
- GSM9360913 DMS114DDP, cisplatin-induced, rep3 DMS114DDP, cisplatin-in…
- GSE278237 Differential gene expression in paired DMS114-Tre vs. DMS114 6 samples same disease briefing · shares dms114
- GSE208446 Small cell lung cancer responds to inhibition of Jumonji enzyme in vitro and in vivo 90 samples same disease briefing · shares small
- GSE255095 An in vivo screening platform using PDX models reveals KEAP1, USP22 and other drivers of chemoresistance in small cell lung cancer 67 samples same disease briefing · shares small
- GSE281525 RNA-sequence data of clinically never-metastatic primary small cell lung cancer cases and small cell lung cancer metastasis cases, FOXA2 knock-down and overexpression in cell lines 61 samples same disease briefing · shares small
- GSE262597 EIF6 conditions drug-tolerant persister-like transdifferentiation in small cell lung carcinoma 56 samples same disease briefing · shares small
- GSE138474 Single-cell analyses reveal increasing intratumoral heterogeneity as an essential component of treatment resistance in small cell lung cancer 43 samples same disease briefing · shares small
- GSE273409 DNAPKCs as a therapeutic target in small cell lung cancer 36 samples same disease briefing · shares small
- GSE303152 Neuronal-Activity Dependent Mechanisms of Small Cell Lung Cancer Pathogenesis 36 samples same disease briefing · shares small
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.